AdvaMed® Statement on Proposed Laboratory Developed Test Rule
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx®, on FDA’s recently proposed LDT rule.